Abstract. Kinetic studies of prothrombin activation and intrinsic factor X activation carried out in the absence and presence ofphospholipids and the protein cofactors Va or VIIIa have provided insight in the mechanism by which the accessory components enhance coagulation factor activation. In intrinsic factor X and prothrombin activation, phospholipids cause a drastic drop of K-for the substrates factor X and prothrombin, whereas the protein cofactors factor Va and factor VIIIa increase V-^* of the prothrombin-and factor X-activating reactions. The mode of action of factor Va in prothrombin activation is however somewhat more complex. Besides its stimulatory effect on the catalytic activity of factor Xa, Factor Va also plays an important role in the assembly of the prothrombin-activating complex at phospholipid surfaces especially when the latter have a low affrnity to1 vitamin-K-dependent coagulation factors. This effect is likely accomplished by promoting the binding of both prothrombin and factor Xa to the procoagulant surface.
Introduction
In the blood coagulation cascade, there are several reactions which require the presence of components, which by themselves have no enzymatic activity but which greatly stimulate coagulation factor activation []. These components, called nonenzymatic cofactors or accessory components, are divided in protein cofactors and negatively charged procoagulant surfaces. Enzyme, substrate and protein cofactors bind to the negatively charged surface and form an enzymatic complex that is optimally active in substrate activation. Thus, in the activation of the coagulation factors XII, XI and prekallikrein, enzyme-substrate interaction is promoted by their binding to negatively charged surfaces like kaolin, glass or sulfatides and by the protein cofactor high-molecular-weight kininogen. For the activation ofthe coagulation factors X and prothrombin the protein cofactors are: factor VIIIa for the intrinsic factor X activation, tissue factor protein for the extrinsic factor X activation and factor Va for prothrombin activation. The procoagulant surface, which promotes prothrombin and also extrinsic and intrinsic factor X activation, consists of phospholipid bilayers that contain negatively charged phospholipids. It is likely that under physiological conditions activated blood platelets provide the procoagulant surface that promotes the assembly of the prothrombin-and intrinsic factor-X-activating complexes since upon stimulation with thrombin plus collagen they expose negatively charged phosphatidylserine in the outer monolayer of their plasma membranes [2, 3] .
The improvement of purification methods of the proteins involved in intrinsic factor X and prothrombin activation and the development of chromogenic substrates specific for thrombin and factor Xa made it possible to obtain via a kinetic approach insight in the role of the accessory components in these reactions. In this paper we will summarize kinetic studies carried out in our laboratory on prothrombin [4, 5] and intrinsic factor X activation [6] . The data obtained allow a precise quantitation of the stimulatory effects of the accessory components and also provide information about their mechanism ofaction in coagulation factor activation.
Effect of the Nonenzymatic Cofactors on the Kinetic Parameters of Prothrombin and Factor X Activation Prothrombin and intrinsic factor X activation are the most intensively studied vitamin-K-dependent clotting factor activation reactions. They have many features in common. Both the enzymes (factor Xa, factor IXa) and the substrates (prothrombin and factor X) are vitamin K-dependent proteins, which contain y-carboxy glutamic acid residues that are important for the Ca2*-dependent binding of these proteins to negatively charged phospholipids. Both enzymes are serine proteases. Also the protein cofactors factor Va and factor VIIIa share several properties. They have no enzymatic activity of their own and both have to be activated by thrombin to express their function in the coagulation factor activation [7, 8] . Also factor V (Va) and factor VIII bind with a high affinity to phospholipid bilayers [9, l0] , although they do not contain y-carboxyglutamic acids.
The importance of the nonenzymatic cofactors is illustrated in table I. We have summarized the effects of the accessory components on the rates of prothrombin and factor X activation. It is clear that phospholipids and the protein cofactor stimulate coagulation factor activation in a multiplicative way. Maximal rates of prothrombin and factor X activation are obtained in the presence of both phospholipids and the protein cofactor (Va or VIIIa). In order to get more insight in the mode of action of phospholipids, factor Va and factor VIIIa in the prothrombin and factor X activation, we have determined their eflects on the kinetic parameters of coagulation factor activation [4, 6] . In the absence as well as in the presence of accessory components, Lineweaver-Burk plots for prothrombin and factor X activation were straight lines from which the kinetic parameters K-and V-u* could be determined. Table II summarizes the effects of the accessory components on the kinetic parameters for prothrombin and intrinsic factor X activation. These data indicate that the role of factor Va and factor VIIIa in prothrombin and factor X activation, respectively, is mainly restricted to an effect on V.u*. reveals that the role of phospholipid in the factor-X-and prothrombin-activating complexes is restricted to an effect on K. for factor X and prothrombin. In the absence of phospholipid, the K-for prothrombin (84pM and factor X (181 1ttr4) are considerably higher than their plasma concentrations (prothrombin 1.5 W, factor X 0.2 PM, whereas upon addition of phospholipid to both complexes, the K-drop to values well below the plasma concentrations. This allows both reactions to proceed at maximal velocity under physiological conditions, provided that a negatively charged phospholipid surface is present.
Mode of Action of Phospholipids in Prothrombin and Factor X Activation Table III shows that the enzymatic complexes for factor X and prothrombin activation cannot be saturated by the addition of increasing amounts of phospholipid. K. is dependent on the phospholipid concentration such that K-for prothrombin and factor X increase with increasing phospholipid concentrations. Thus, K. measured in the presence of phospholipid must be regarded as an apparent Kn' (K."oo), which is a function of the phospholipid concentration in the reaction mixture.
In hgure l, three models are presented which can explain the drop in Kn' after phospholipid addition as well as the apparent character of this kinetic parameter. The models are given for prothrombin activation in the absence of factor Va and are presumably also valid for intrinsic factor X activation in the absence of factor VIIIa. Model I illustrates the situation in which a phospholipidbound factor Xa molecule has a conformational state (asterisk) different from the factor Xa molecules in free solution. This conformational change of phospholipid-bound factor Xa causes an increase of the affinity of this molecule for prothrombin molecules which are present in free solution. This increased affinity between enzyme and sub-strate will result in a lowered K-"oo for prothrombin.
Also in model 2, prothrombin molecules originating from free solution interact directly with phospholipid-bound factor Xa molecules, but in this model the bound factor Xa molecules have not undergone a conformational change. Binding of prothrombin to phospholipid-bound factor Xa is promoted by the additional affrnity of prothrombin to negatively charged phospholipid molecules in the direct environment of the factor Xa molecule (dashed circle). Both in model 1 and model 2, the saturation of factor Xa is directly dependent on the concentration of prothrombin free in solution. When the phospholipid concentration is increased, more prothrombin is bound to phospholipid leaving less prothrombin in solution available for interaction with phospholipid-bound factor Xa. To obtain half maximal saturation (i.e, K-conditions) of factor Xa with prothrombin, more prothrombin must be added at higher phospholipid concentrations. Since K-for prothrombin is expressed in terms of the concentration of total added prothrombin, K-uoo will be higher at higher phospholipid concentrations (cf. tabte ItI;.
In model 3, phospholipid-bound factor Xa activates phospholipid-bound prothrombin. In this model, half maximal saturation of bound factor Xa is determined by the local concentration of phospholipidbound prothrombin. The fact that the local prothrombin concentration at the phospholipid surface is higher than that in free solution explains the phospholipid-dependent decrease of K-for prothrombin. However, when the phospholipid concentration is again increased, the bound prothrombin molecules are diluted at the phospholipid surface and more prothrombin must be parameters of prothrombin and added to restore the local concentration of phospholipid-bound prothrombin required for half saturation of phospholipid-bound factor Xa. Thus, when K* is expressed in terms of total prothrombin concentration, also in model J, Kmann will increase at increasing phospholipid concentrations. In this model, it is expected, that, although K.uoo increases with the phospholipid concentration, a K--expressed in terms of prothrombin surface density would be constant. Using binding parameters reported by Nelsestuen and Broderirs [11] we calculated prothrombin and factor X surface densities at the K. presented in table IIL Figure 2 compares the measured Kmann for prothrombin or factor X with the surface density of bound prothrombin and factor X, at the Ko concentrations. It is obvious that K' expressed in terms of surface density is independent of the phospholipid concentration, as might be expected in model 3.
In model I and model 2, the concentration of free substrate at K*uoo must be independent of the phospholipid concentration. Figure 2 shows that also the free prothrombin and factor X concentration at K-are independent of the phospholipid concentratlon. Thus, on the basis of these calculations, we cannot distinguish between the three proposed models, since both the free substrate concentration (requirement of model I and 2) and the surface density of substrate (requirement of model 3) are independent of and constant at diflerent phospholipid concentratrons. Table IV shows the effect of variation of the molar fraclion of phosphatidylserine in phospholipid vesicles on the kinetic parameters of prothrombin activation. In the absence of factor Va, vesicles containing 400/o phosphatidylserine exhibit a 4O-fold lower K-uoo than vesicles containing 2.50/o phosphatidylserine. Prothrombin aflinity for phospholipid vesicles has been shown to increase at increasing content of phosphatidylserine in these vesicles [1 l]. Therefore, the difference in K-uoo measured with phospholipid vesicles containing varying molar percentages phosphatidylserine is likely caused by differences of the afhninty of prothrombin for these vesicles. In models 2 and 3, a lower affinity of prothrombin for phospholipid results either in a lower affinity of the factor Kinetic parameters were determined at a phospholipid concentration of 50 pM. PS = Phosphatidylserine; pf = phosphatidylcholine.
Kinetic parameters were determined at a phospholipid concentration of 50 FM.
Xa-phospholipid unit for prothrombin (model 2) or in a decreased prothrombin density at the phospholipid surface (model 3), which in both cases will result in an increase of K-. In model 1, the charge of the phospholipid surface is expected to be unimportant for the conformational state of the phospholipid-bound factor Xa, and moreover a decreased prothrombin binding to phospholipid will result in an increase of the concentration of prothrombin free in solution, which will cause a further decrease of Km"ee. We feel that on this basis and from the observation that acarboxyprothrombin, which has a reduced amount of 1-carboxyglutamic acids, gives in the presence of phospholipids much lower reaction rates than prothrombin [12] , the conformational model (model l) is Iess likely.
Also the V-u* of prothrombin activation depends on the amount of phosphatidylserine in the phospholipid vesicles. At lower molar percentages of phosphatidylserine, lower V-u* values are observed. This is likely caused by the fact that these vesicles have a lower affinity for factor Xa and thus bind less factor Xa, which will decrease the amount of factor Xa that participates in prothrombin activation. This will result in the observation of lower V-.* values.
The Role of Factor Va in Prothrombin Activation
As we have seen in table II, the stimulatory effect of factor Va on prothrombin activation in the presence of phospholipid vesicles with a high molar percentage of phosphatidylserine must be attributed to an increase of Vmax [cf. a]. More recently it was observed that factor Va also lowers K-for prothrombin for membranes with a low affinity for prothrombin [5, l3] . This effect of factor Va on K-for prothrombin will be discussed later.
The increase of the Vma* by factor Va is the result of three additive effects: (1) a shift in the reaction pathway of factor-Xa-catalyzed prothrombin activation l4l, (2) an increase of a forward rate constant in the prothrombin activation pathway [4] and (3) an increase of the amount of factor Xa that participates in prothrombin activation [5, 16] . Figure 3 gives the minimal reaction mechanism for prothrombin activation that will be helpful to explain the factor-Va-induced shift in the prothrombin activation pathway. Gelelectrophoretic analysis has shown that in the absence of factor Va prethrombin 2 is the main product of prothrombin activation [4] . This shows that the major reaction pathway occurring under these conditions is that represented by steps 1,2 and 5, and it also indicates that prethrombin 2 easily dissociates from factor Xa. In the presence of factor Va there is almost no prethrombin 2 formation, and thrombin is the major activation product. Thus, factor Va changes the pathway of prothrombin activation from one producing prethrombin 2 (steps l, 2, 5) into one giving rise to thrombin (steps 1-4). Apparently, the presence of factor Va prevents the dissociation of prethrombin 2 from the prothrombinase complex, thereby increasing the rate of thrombin formation.
Based on the estimation of the rate constants of prethrombin 2 formation (without factor Va) and thrombin formation (with factor Va), Tans et al. [7] concluded that apart from the shift in the pathway factor Va must also increase at least one forward rate constant of the prothrombin activation pathway. This was indeed shown to be the case by Nesheim and Mann in 1983 [4] . From kinetic experiments with prothrombin and prothrombin activation intermediates they concluded that factor Va causes a 3,000-fold increase of the k"u, of the factor-Xa-catalyzed cleavage of the Arg323-Thr32a bond in prothrombin (hg. 3 step 3).
The third effect of factor Va on V-u* of prothrombin activation concerns its ability to promote the binding of factor Xa to negatively charged phospholipid vesibles [ 5, 16] . Especially for membranes with a low affinity for factor Xa, this property of factor Va will contribute to the increase of the V."*. This phenomenon becomes clear upon comparison of the effects of procoagulant surfaces with different phosphatidylserine content on V-u* measured in the absence (table IV) or  presence of factor Va (table V) . Without fac-tor va there rs a considerable decrease of accomplished by (1) a direct interaction of v-"* at low molar percentages of phosphati-prothrombin with factor va' (2) a factor-vadylserine. This is likely ca-used by the fact induced clustering of negatively charged that these membranes hu,,.. u low a{Iinity for phospholipid molecules around the enzyfactor Xa [11] hence less factor Xa will par-matic unit that creates a better surface for ticipate in prothrombin activation and lower prothrombin binding or (3) a factor-va-tnv_.* values will be observed. However, in iuced increase of a rate constant in the paththe presence of factor Va there is hardly any effect of ',ra.iation of the molar percentage of phosphatidylserine on V-u* of prothrombin activation (table V) . This indicates that under these conditions all added factor Xa par-proteases: H'fii",'#"ffi"T"#,o;:;:::"#:tiT?lill-e+s5 u'+ s4 k" E* \ branes for factor Xa. This can be attributed in which to the fact that factor Va has the ability to promote the binding of factor Xa to the phos"-u.,, = ffi and K' = *''[*j pholipid vesicles' ,rrpnrc nf facrnr va on r., tt is ,,,..rrunlr-it is possible rhat an Apart from the effects of factor Va o V."*,tableValsoshowsaneffectoffactorincreaseofasinglerateconstant(k;)brfacVaonK.forprothrombinwhenphospho-torVacancauseanincreaseofk.".anda lipid vesicles with a low molar percentage decrease of K-. At present u'e cannot give phosphatidylserine are used as procoagulant preference to either of the three models stnce surface. In the absence of factor va, low mo-p.op., kinetic data that would allo* discrimlar percentages of phosphatidylserine gave ination are not yet available' high K-values. This could be easily exptaineO in models I and 2 ( fig' 2) , in which lhe *eak affinity of prothrombin for the phospholipid surface of vesicles containing Conctuding Remarks low molar percentages of phosphatidylserine The most important contribution of the phospholipid surface in the actir ation of vitamin-K-dependent coagulation factors ts to promote the interactions betueen the proin the vesicles. So apparently, factor va com-teins involved in these reactions' For this pensates for the toss of binding affrnity of stimulatory effect, the proteins must har-e the prothrombin for this kind of membrane sur-ability to bind to the procoagulant surface' faces. several explanations are possible for The stimulation by surface is caused bl' the the observation that factor va lowers K. of fact that the proteins have an affinitl' for the prothrombinforprocoagulantmembranesphospholipidsurfaceandforeachother.a with a low aflinity for vitamin-K-dependent combination which ensures effrcient proteincoagulation factors. This phenomenon can be protein interactions at the surface' Thus' phopholipids stimulate prothrombin and factor X activation by facilitating enzyme-substrate complex formation -a phenomenon which is reflected in a large drop of K. of their respective substrates.
The functions of the nonenzymatic protein cofactors, factors Va or VIIIa, are most easily explained on the basis ofthe effects of factor Va in prothrombin activation. It is shown that factor Va acts in prothrombin activation by enhancing the catalytic efficiency of factor Xa, and by assembling factor Xa and prothrombin to an enzymatic complex at the phospholipid surface.
The marked effects of factor Va on the kinetic parameters of prothrombin activation, which are found in the presence of phospholipid vesicles with a weak affinity for factor Xa and prothrombin, are likely of physiological importance. It is generally accepted that in vivo stimulated blood platelets provide the procoagulant phospholipid surface that serves the activation of prothrombin and factor X since activated platelets expose phosphatidylserine in the outer monolayer of their plasma membrane. After activation with physiological platelet activators (collagen plus thrombin), the platelet outer monolayer contains, about 5 mol0/o phosphatidylserine [1] . Such a membrane surface would show weak interactions with prothrombin and factor Xa in the absence of factor Va. Therefore, factor Va will also play an important role in the assembly of the prothrombinactivating complex at the surface of blood platelets. Since prothrombin and factor X activation have many common features, it is likely that phospholipids, factor VIIIa and activated blood platelets act in a similar way in intrinsic factor X activation as the corresponding cofactors in prothrombin activatron.
